2C-P: Difference between revisions
>David Hedlund m m |
>David Hedlund m |
||
Line 18: | Line 18: | ||
Pharmacokinetic factors that make 2C-P pretty unique and require notably caution: | Pharmacokinetic factors that make 2C-P pretty unique and require notably caution: | ||
* Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" / | * Steep dose-response curve: As little as a few extra milligrams separating a manageable dose and an overdose.<ref name="Erowid" /> | ||
* Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> | * Very slow onset: The peak effects reportedly do not occur for 1 to 3 hours.<ref name="Erowid">{{Citation | title=Erowid Online Books : “PIHKAL” - #36 2C-P | url=https://www.erowid.org/library/books_online/pihkal/pihkal036.shtml}}</ref> | ||
* Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref> | * Long half-life: The anecdotal estimated elimination half-life is 19 hours.<ref>https://pubmed.ncbi.nlm.nih.gov/28130544/</ref> |